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ABSTRACT

22

The following protocol describes our workflow for processing wastewater with the goal of

23

detecting the genetic signal of SARS-CoV-2. The steps include pasteurization, virus

24

concentration, RNA extraction, and quantification by RT-qPCR. We include auxiliary steps that

25

provide new users with tools and strategies that will help troubleshoot key steps in the process.

26

This protocol is one of the safest, cheapest, and most reproducible approaches for the detection

27

of SARS-CoV-2 RNA in wastewater. Furthermore, the RNA obtained using this protocol, minus

28

the pasteurization step, can be sequenced both using a targeted approach sequencing specific

29

regions or the whole genome. The protocol was adopted by the New York City Department of

30

Environmental Protection in August 2020 to support their efforts in monitoring SARS-CoV-2

31

prevalence in wastewater in all five boroughs of the city. Owing to a pasteurization step, it is

32

safe for use in a BSL1+ facility. This step also increases the genetic signal of the virus while

33

making the protocol safe for the personnel involved. This protocol could be used to isolate a

34

variety of other clinically relevant viruses from wastewater and serve as a foundation of a

35

wastewater surveillance strategy for monitoring community spread of known and emerging viral

36

pathogens.
1
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38

Introduction
The tracking of SARS-CoV-2 infections has most often involved the detection of SARS-

39

CoV-2 RNA via RT-qPCR in biological samples obtained from patients that develop some of the

40

symptoms associated to COVID-19 [1]. One of the disadvantages of this approach is that if

41

much of the transmission within a population is asymptomatic or unsampled, infections from

42

these individuals may be overlooked [2,3]. Additionally, SARS-CoV-2 sequencing efforts, while

43

occurring at a much faster rate and larger, more global scale than in previous pandemics, suffer

44

biases because genomic information is often obtained from seriously ill patients, but not from

45

patients who do not seek medical attention, which include asymptomatic patients, and those

46

with mild symptoms who choose to follow the CDC’s advice and convalesce at home. If most

47

transmission within a population is asymptomatic or unsampled, genomes from these

48

individuals are expected to represent most of the viral population circulating within the

49

community. Recently the discovery of novel variants of concern in different regions of the world

50

has added another challenge [4,5], which is to monitor the proportion of individuals that carry a

51

particular variant in a geographical area. Given that SARS-CoV-2 has been detected in fecal

52

samples [6,7], and subsequently in wastewater [3,8,9], wastewater is being tested in cities

53

around the world to determine SARS-CoV-2 prevalence in communities [10-12]. Furthermore,

54

isolation of SARS-CoV-2 RNA from wastewater coupled with high-throughput deep sequencing

55

provides an almost unlimited source of unbiased viral sequences, which can be used to monitor

56

frequencies of variants of concern in populations.

57

With the goal of sequencing SARS-CoV-2 RNA from wastewater, we developed a

58

protocol to extract and quantify viral RNA. The initial step in the development of this protocol

59

was the decision to pasteurize our samples at 60  for an hour on arrival at the laboratory.

60

Given that SARS-CoV-2 is a biosafety level 3 (BSL3) agent, inactivation of the virus before

61

processing is often required before samples can be processed in BSL2+ or BSL1+ laboratories.

62

Happily, as we report here, pasteurization did not impair our ability to detect SARS-CoV-2, but
2
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63

instead, improved it. Interestingly, while SARS-CoV-2 recovery was not impaired, control spike-

64

in viruses bovine coronavirus (BcoV) [13] and bacteriophage Phi6 [14] were barely detectable

65

using RT-qPCR and PCR respectively. Subsequently, control viruses were spiked-in after

66

pasteurization. We are currently studying the effect of pasteurization on the quality of our

67

sequencing data. Preliminary results suggest that the output and quality of sequencing data

68

may be better with unpasteurized samples, therefore if the intention of the study is to sequence

69

SARS-CoV-2 from wastewater, we recommend skipping the pasteurization step.

70

A second major decision was to employ centrifugation and filtering (0.2 µM) to remove

71

the wastewater solids. While it was acknowledged that SARS-CoV-2 may associate with the

72

solids, removing the solids facilitates downstream processing steps, and may remove genomic

73

contamination that would impair our ability to deep sequence SARS-CoV-2. As a counterpoint,

74

filtration is one of the more expensive steps of the protocol so those desiring to reduce costs

75

may consider eliminating filtration. We were able to acquire consistent results with and without

76

filtration, and neither strategy resulted in a significant increase in our ability to quantify SARS-

77

CoV-2.

78

Since viruses are greatly diluted in wastewater, virion concentration is a significant

79

challenge. We considered three common protocols to concentrate SARS-CoV-2 virus present in

80

the water: ultracentrifugation [15], skimmed milk flocculation [16], and polyethylene glycol

81

(PEG)/sodium chloride (NaCl) precipitation. High speed centrifugation was ruled out as

82

impractical for the volumes needing to be processed. Precipitation/flocculation using PEG/NaCl

83

or skimmed milk eliminates the need for high-speed ultracentrifugation and generates sufficient

84

RNA for viral quantification with RT-qPCR (i.e., resulting in Cts < 40). However, in our

85

experiments, PEG/NaCl precipitation performed marginally better than skim milk flocculation

86

and does not introduce additional genetic material to our samples, so this was chosen as our

87

concentration method. As we expanded our experiment to include sequencing the RNA from

3
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88

wastewater, we explored the effect of longer incubation times on viral RNA recovery. Longer

89

storage in PEG/NaCl led to slightly greater recovery.

90

As we were mindful of the need to find cost effective solutions, we investigated

91

alternative, kit-free approaches to RNA isolation. In our hands, TRIzol (ThermoFisher Inc.)

92

performed better than the QIAamp Viral RNA Mini kit (Qiagen Inc.). As TRIzol is cheaper per

93

sample than column-based kits, we adopted it for the final protocol. An added benefit of TRIzol

94

relevant to downstream sequencing applications is that TRIzol segregates RNA in a separate

95

layer from DNA, unlike column-based isolation kits, which isolate both RNA and DNA.

96

In addition to the RNA isolation method, we compared the performance of different RT-

97

qPCR enzymes, TaqPath 1-Step RT-qPCR enzyme (Thermofisher Inc.) and One Step

98

PrimeScript III enzyme (Takara Bio USA Inc. The RT enzyme from Takara was 25% cheaper

99

and had a similar performance to Taq-Path so we chose it for the final protocol. A broader

100

investigation of different enzymes may identify other satisfactory, cost-effective solutions.

101

Our protocol provides a reproducible and low-tech approach that allows the detection

102

and quantification of SARS-CoV-2. Pasteurization of the sample at the very beginning of the

103

protocol ensures the safety of the user. Preliminary results suggest that pasteurization may also

104

release the virus bound to the wastewater solids, enhancing recovery. Filtering and PEG/NaCl

105

concentration simplifies downstream processing. The extraction of RNA using TRIzol reduces

106

the cost significantly when compared to extraction column-style protocols using commercial kits.

107

We have been able to do both targeted and whole genome sequencing of the SARS-CoV-2

108

genome using this protocol but recommend removing the pasteurization step if this is the main

109

goal of the experiments.

110

Our protocol performed strongly in a large-scale, nationwide comparative study of the

111

reproducibility and sensitivity of 36 methods of quantifying SARS-CoV-2 in wastewater [17]. Our

112

protocol is identified as 4S.1(H) in Table 3. In addition, the Pecson et al. study offers strong

113

support for several of the primary claims of the present paper. First, the removal or non-removal
4
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114

of the wastewater solids did not show a clear systematic impact on outcomes. Second,

115

pasteurization resulted in a small, but significant, increase in recovery. Third, methodological

116

differences between teams had minimal impact on reproducibility and sensitivity, thus indicating

117

that our modifications to implement cheaper, simpler methods will not impair SARS-2-CoV-2

118

detection and quantification relative to other strategies.

119

We recognize that our protocol has some limitations. Our current protocol isolates the

120

RNA from 40 ml of wastewater and requires access to a centrifuge capable of reaching 12,000 x

121

g. Thus, scaling up the volume of samples from 40 ml or increasing the number of individual

122

samples, represents a challenge. Our protocol requires filtration units which are dependent on

123

the supply chain. Additionally, extracting RNA with TRIzol requires the user to take care not to

124

contaminate the aqueous phase with organic material after centrifugation, which can be difficult

125

for inexperienced users. Nevertheless, the basic protocol and techniques involved is

126

economical, simple, and reproducible when compared to alternative strategies.

127
128

Materials and Methods

129

“The protocol described in this article is published on protocols.io,

130

dx.doi.org/10.17504/protocols.io.brr6m59e and is included for printing as file S1.”

131
132

Expected Results

133

Our protocol results in the reproducible isolation and quantification of SARS-CoV-2 RNA from

134

wastewater samples (Fig. 1). Enough RNA can be acquired for RT-qPCR, and isolated RNA is

135

suitable for whole genome amplification and sequencing (although pasteurization is not

136

recommended if the intention is to sequence SARS-CoV-2 RNA isolated from wastewater). As a

137

general note, wastewater treatment plants indicated in our figures have been deidentified. There

138

is no correspondence between the numerical wastewater treatment plant (WWTP) IDs in

139

different figures. Moreover, experiments described in different figures were performed at
5

medRxiv preprint doi: https://doi.org/10.1101/2021.02.16.21251787; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

140

different times using different wastewater samples. Our purpose here is not to report regional

141

prevalence, but rather to demonstrate the reliability and consistency of our protocol.

142
143

Figure 1. Repeatability of Protocol: Copy number yield for the N1 target for 24-hr composite

144

wastewater samples obtained from all 14 wastewater treatment plants (WWTP) in New York

145

City demonstrating reproducibility of our protocol. Each point is the mean of two technical

146

replicate measurements from a 24-hour composite sample. All samples collected and initially

147

processed on the same day. Error bars are ±SEM. Some error bars are too small to be visible.

148

Samples 2 and 11 are from plants with a significant influx of ocean water, but it is not clear if this

149

is driving variation in these sites.

150

Key steps were optimized during the development phase of our protocol. Initially we

151

used Phi6 [14] as a spike in control. However, we found that Phi6 was rapidly degraded in the

152

pasteurization step of our protocol. Reports from the scientific community suggested that BCoV

153

would serve as a better control, however, we found that BCoV was significantly degraded by

154

pasteurization as well. Consequently, we switched to spiking samples with BCoV after

155

pasteurization and before the first centrifugation to remove solids. It would be interesting to

156

determine why BCoV was rapidly degraded by pasteurization, but an ostensibly similar virus,

157

SARS-CoV-2, was not.
6
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158

To ascertain the impact of pasteurization on SARS-CoV-2 quantitation, a single

159

California wastewater sample was divided into ten parts. Five of these replicate samples were

160

pasteurized and five were not. The positive impact of pasteurization on SARS-CoV-2

161

quantification is reflected in the increase of N1 copies/L of pasteurized versus unpasteurized

162

samples (Fig. 2; paired t-test: t = 7.191, df = 4, p = 0.002). We speculate that incubation of

163

samples at 60  contributes to release of virus from wastewater solids. As an additional

164

advantage, pasteurization appears to increase repeatability of sample quantification. The pooled

165

variance for pasteurized and unpasteurized samples were 0.005 and 0.177 respectively. We

166

conclude that pasteurization results in greater sensitivity and more precise estimates of SARS-

167

CoV-2 prevalence. Similar outcomes have been reported elsewhere [17].

168

169
170

Figure 2. Effect of Pasteurization: Copy number yield for the N1 target obtained from one

171

California 24-hr composite wastewater sample processed either with pasteurization or without

172

pasteurization. Each point is the mean of 5 independent assays. Error bars are ±SEM. A paired

173

t-test revealed significant differences between the treatments (t = 7.191, df = 4, p = 0.002).

174
7
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175

In previous work on bacteriophages, we had observed that longer PEG/NaCl incubation

176

times increased phage recovery. To determine if longer incubation similarly impacts SARS-CoV-

177

2 recovery, we compared SARS-CoV-2 quantitation for samples incubated in PEG/NaCl for 24

178

hrs versus 48 hrs. We found that 48 hrs incubation significantly increased sample yield (Fig. 3;

179

RM ANOVA: F = 398, P = 0.0003). This result should ameliorate concerns about longer term

180

storage of wastewater samples if they cannot be processed immediately. In our hands, SARS-

181

CoV-2 quantitation was not impaired in the short term by storage at 4 °C either with or without

182

PEG/NaCl, an outcome similarly reflected by other studies [18, 19]. However, storing the

183

pasteurized samples at 4  for 72 hours without added PEG and NaCl negatively impacted the

184

recovery of N1 copies by RT-qPCR.

185
186

Figure 3. Effect of Storage Time: Following initial processing (pasteurization, preliminary

187

centrifugation, and filtering), 24-hr composite samples from 3 different wastewater treatment

188

plants were stored in a PEG/NaCl solution for precipitation and concentration of virions.

189

Samples stored in PEG/NaCl solution for 48-hrs are labeled by dark blue circles; samples

190

stored in PEG/NaCl solution for 24-hrs are labeled by light blue circles. Each point is the mean

191

of two technical replicate measurements from a 24-hour composite sample. Error bars are

192

±SEM. Some error bars are too small to be visible. A repeated measures ANOVA indicated that
8
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193

48-hrs storage in PEG/NaCl resulted in significantly greater yields than did storage for 24-hrs (F

194

= 398, P = 0.0003).

195
196

The pellet obtained after centrifugation of the wastewater sample (with added PEG and

197

NaCl) is not visible to the naked eye in most cases and is usually distributed along the side of a

198

polypropylene Oak Ridge tube. Additionally, it takes time to dissolve the pellet in TRIzol, and

199

premature decanting may leave residual RNA unrecovered. Therefore, untrained users often

200

resuspend the pellet incompletely, resulting in the loss of valuable RNA. To aid in visualizing the

201

pellet, we added safranin at 0.2% final concentration immediately before centrifugation. Safranin

202

did not interfere with downstream processing (Fig. 4). When safranin is added, a pale pink pellet

203

is easily visible. The video uploaded as Supplementary Material (S2) shows how long it takes to

204

dissolve the pellet in TRIzol. This strategy of adding safranin is particularly useful for training

205

purposes.

206
207

Figure 4. Effect of Safranin Staining: Copy number yield for the N1 target for 24-hr composite

208

wastewater samples obtained from 3 wastewater treatment plants. Samples processed with

209

safranin are labeled by dark blue circles; controls are labeled with light blue circles. Each point

210

is the mean of 4 technical replicate measurements from a 24-hour composite sample. Error bars
9
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are ±SEM. Some error bars are too small to be visible. A repeated measures ANOVA revealed

212

that safranin staining improved virus recovery (F= 15.10, P = 0.006). This effect is likely a result

213

of better visibility of the RNA pellet during recovery.

214
215

To explore the cheapest alternatives of extracting RNA from wastewater samples we

216

compared a widely used column-based QIAamp Viral RNA Mini kit (Qiagen Inc.) with TRIzol

217

(ThermoFisher Inc.). TRIzol facilitates significantly better RNA recovery than the kit at a fraction

218

of the cost (Fig. 5; RM ANOVA: F= 1441, P < 0.0001). We note that we also found phenol-

219

chloroform extraction to be less consistent than TRIzol on saliva samples, so while phenol-

220

chloroform is likely even cheaper, we advise against its use in this protocol. TRIzol was

221

therefore chosen as the organic extraction method to compare with column approaches.

222

Importantly the supply of TRIzol is less impacted by supply chain issues. Additionally, TRIzol

223

removes DNA, but retains RNA, whereas column-based kits are unable to do so. If the intention

224

is to sequence RNA obtained from wastewater samples, TRIzol extraction provides a cleaner

225

sample with less contaminating DNA from non-SARS-CoV-2 genomes. As a caveat, because

226

TRIzol requires the careful extraction of an aqueous layer from a multilayered solution, TRIzol

227

extraction requires training and is best performed by experienced users.

10
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228
229

Figure 5. Effect of TRIzol Extraction: Copy number yield for the N1 target for 24-hr composite

230

wastewater samples obtained from 5 wastewater treatment plants. Samples processed with

231

TRIzol are labeled by dark blue circles; samples processed with the QIAamp Viral RNA Mini Kit

232

are labeled with light blue circles. Each point in the mean of 2 technical replicate measurements

233

from a 24-hour composite sample. Error bars are ±SEM. Some error bars are too small to be

234

visible. A repeated measures ANOVA revealed that the use of TRIzol significantly improved

235

virus RNA recovery (F= 1441, P < 0.0001).

236
237

In addition to comparing RNA isolation methods, we evaluated the performance of

238

different enzymes, including the TaqPath 1-Step RT-qPCR enzyme (ThermoFisher Inc.) and

239

One Step PrimeScript III enzyme (Takara Bio USA Inc.) Our results indicated that the One Step

240

PrimeScript III enzyme gave slightly better results (Fig. 6). As the One Step PrimeScript III

241

enzyme was 25% cheaper and performed similarly to the ThermoFisher enzyme, we chose the

242

PrimeScript III enzyme for the final protocol.

11
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244

Figure 6. Effect of Different RT-qPCR Enzymes: Copy number yield for the N1 target for 24-

245

hr composite wastewater samples obtained from 6 wastewater treatment plants (WWTP). RT-

246

qPCR assays performed with the TaqPath 1-Step RT-qPCR enzyme (ThermoFisher Inc.)

247

recommended by the CDC [20] are labeled by light blue circles; RT-qPCR assays performed

248

with One Step PrimeScript III enzyme (Takara Bio USA Inc.) are labeled with dark blue circles.

249

Each point in the mean of 2 technical replicate measurements from a 24-hour composite

250

sample. Error bars are ±SEM. Some error bars are too small to be visible. A repeated measure

251

ANOVA revealed that the use of the PrimeScript III enzyme improved virus RNA recovery (F=

252

13.09, P = 0.011).

253
254

The need to adapt wastewater surveillance detection programs to include variant

255

detection requires deep sequencing of cDNA generated from the wastewater RNA. Our

256

preliminary results have shown that RNA extracted with our PEG/TRIzol protocol can be

257

sequenced using both traditional Sanger sequencing and NGS technology. However, we also

258

note that pasteurization reduced sequencing quality and output relative to unpasteurized

259

samples, so we recommend skipping this step if the intention is to sequence RNA obtained from

260

wastewater.
12
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261

We used both the Swift Normalase® Amplicon Panel (SNAP) SARS-CoV-2 Panel kit as

262

well as the Qiagen QIAseq® SARS-CoV-2 Primer Panel and QIAseq FX DNA Library kit and

263

have obtained SARS-CoV-2 sequences from several of our wastewater treatment plants.

264

Known and novel variants were identified. We continue to optimize and improve our library

265

preparation methods to increase both length of coverage and depth of coverage for our NYC

266

samples. In addition, we are developing real-time assays for the identification and quantification

267

of additional viruses that circulate among our New York communities including Influenza.

268
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